Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

PVCT Relative to the S&P 500

PVCT Relative to the Sector

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Provectus Pharmaceutical Inc (OTCMKT:PVCT) seasonal charts above shows that a Buy Date of December 20 and a Sell Date of March 28 has resulted in a geometric average return of 20.85% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 16 of those periods. This is a very good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 42.45% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Provectus Biopharmaceuticals, Inc. is a development stage biopharmaceutical company, which engages in the development of ethical pharmaceuticals for oncology and dermatology indications. Its prescription drugs treat several life-threatening cancers including metastatic melanoma, liver cancer, and breast cancer. The company was founded by Eric A. Wachter on January 17, 2002 and is headquartered in Knoxville, TN.

To download PVCT seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: PVCT